Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

500 trials

2024-513022-29-00
Recruiting
A study to evaluate Samyr effectiveness and safety profile. The study is done by comparing that Samyr injection is better than placebo injection in subjects with depression which are treated regularly with antidepressant tablet treatment.
Phase 3 · Italy · 3 sites
Registry update: 6 Aug 2026
NCT04061148
Recruiting
Near Infrared Spectroscopy (NIRS) for Assessment of Depression
Not applicable · United States · 1 site
Registry update: 11 Sept 2026
NCT04748276
Recruiting
Tracking Response to Antidepressants in Advance of Investigational Trials
Not applicable · United States · 1 site
Registry update: 27 Oct 2026
NCT03953014
Recruiting
Pharmacogenetics of Antidepressant-Induced Disinhibition
Not applicable · Canada · 1 site
Registry update: 14 May 2026
NCT04975724
Recruiting
A randomized, double-blind, placebo-controlled, multicenter clinical trial to assess safety and effectiveness of Liposom in enhance and speed up response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD)
Phase 4 · Italy · 3 sites
Registry update: 23 Dec 2025
NCT03665831
Recruiting
Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults
Not applicable · Canada · 1 site
Registry update: 27 Oct 2025
NCT03388606
Recruiting
Characterization and Treatment of Adolescent Depression
Not applicable · United States · 3 sites
Registry update: 26 Oct 2026
NCT03320304
Recruiting
A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.
Not applicable · Austria, Belgium, Germany, United Kingdom · 18 sites
Registry update: 27 Aug 2026
NCT03272698
Recruiting
ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression
Phase 4 · Canada · 1 site
Registry update: 23 Jan 2025
NCT04637620
Recruiting
NMDA Modulation in Major Depressive Disorder
Phase 2 · Taiwan · 1 site
Registry update: 23 Oct 2026
NCT03065335
Recruiting
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Phase 1 · United States · 1 site
Registry update: 9 Nov 2026
NCT02752542
Recruiting
Personalized Indications for CBT and Antidepressants in Treating Depression
Phase 4 · Canada · 1 site
Registry update: 14 May 2025
NCT06580860
Recruiting
Psychiatric Multi-omics and Neuroimaging Project
Not applicable · China · 1 site
Registry update: 13 Mar 2026
NCT02543983
Recruiting
Neurobiology of Suicide
Phase 2 · United States · 1 site
Registry update: 16 Oct 2026
NCT02434393
Recruiting
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Not applicable · United States · 2 sites
Registry update: 25 Nov 2025
NCT04296604
Recruiting
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
Not applicable · United States · 1 site
Registry update: 10 Sept 2025
NCT02122562
Recruiting
Ketamine Alcohol (in Treatment-Resistant Depression)
Phase 2 · United States · 1 site
Registry update: 1 May 2026
NCT01980147
Recruiting
Skills for Wellness
Not applicable · Canada · 1 site
Registry update: 14 May 2025
NCT05388461
Recruiting
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
Not applicable · Norway · 2 sites
Registry update: 26 Sept 2023
NCT00018057
Recruiting
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
Phase 2 · United States · 2 sites
Registry update: 9 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.